Edition:
India

Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

4.23USD
25 Sep 2020
Change (% chg)

$-0.07 (-1.63%)
Prev Close
$4.30
Open
$4.27
Day's High
$4.40
Day's Low
$4.22
Volume
48,207
Avg. Vol
143,673
52-wk High
$7.66
52-wk Low
$1.90

Select another date:

Thu, Jun 18 2020

BRIEF-Adamas Provides Program Update For ADS-5102 For Multiple Sclerosis Patients With Walking Impairment

* ADAMAS PROVIDES PROGRAM UPDATE FOR ADS-5102 FOR MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT

BRIEF-Adamas Announces FDA Filing Acceptance Of SNDA To Modify The Indication Statement For Gocovri® To Include Treatment For Parkinson’S Disease Patients Receiving Levodopa And Experiencing Off Episodes

* ADAMAS ANNOUNCES FDA FILING ACCEPTANCE OF SNDA TO MODIFY THE INDICATION STATEMENT FOR GOCOVRI® TO INCLUDE TREATMENT FOR PARKINSON’S DISEASE PATIENTS RECEIVING LEVODOPA AND EXPERIENCING OFF EPISODES

BRIEF-Adamas Announces Issuance Of New U.S. Patent For Gocovri In Parkinson's Disease

* ADAMAS ANNOUNCES ISSUANCE OF NEW U.S. PATENT FOR GOCOVRI IN PARKINSON'S DISEASE Source text for Eikon: Further company coverage:

Select another date: